Cost-Effectiveness of Molecularly Guided Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) in Patients under 60

SIMPLE SUMMARY: Diffuse large B cell Lymphoma (DLBCL) can be categorized into cell of origin (COO) subtypes. Genetic tests are used to detect which subtype of DLBCL a patient has. One subtype of DLBCL, activated B-cell like (ABC), is associated with a comparatively poorer prognosis. New evidence sug...

Descripción completa

Detalles Bibliográficos
Autores principales: Regier, Dean A., Chan, Brandon, Costa, Sarah, Scott, David W., Steidl, Christian, Connors, Joseph M., Karsan, Aly, Marra, Marco A., Kridel, Robert, Cromwell, Ian, Pollard, Samantha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870002/
https://www.ncbi.nlm.nih.gov/pubmed/35205656
http://dx.doi.org/10.3390/cancers14040908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870002/
https://www.ncbi.nlm.nih.gov/pubmed/35205656
http://dx.doi.org/10.3390/cancers14040908

Ejemplares similares